IO Biotech, Inc.

NasdaqGS:IOBT Stock Report

Market Cap: US$60.6m

IO Biotech Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

NasdaqGS:IOBT Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
23 Dec 24BuyUS$9,720Devin SmithIndividual12,000US$0.81
23 Dec 24BuyUS$8,483Amy SullivanIndividual10,250US$0.83
23 Dec 24BuyUS$10,120Mai-Britt ZoccaIndividual12,500US$0.81
23 Dec 24BuyUS$26,553Qasim AhmadIndividual31,350US$0.85
16 Sep 24SellUS$785,925Novo Holdings A/SCompany1,000,000US$0.83
26 Jul 24SellUS$99,125Novo Holdings A/SCompany75,000US$1.33
10 May 24SellUS$802,495Novo Holdings A/SCompany658,809US$1.22
09 Feb 24SellUS$988,411Novo Holdings A/SCompany658,809US$1.50

Insider Trading Volume

Insider Buying: IOBT insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of IOBT?
Owner TypeNumber of SharesOwnership Percentage
Individual Insiders220,8910.335%
Institutions12,215,46918.5%
General Public15,560,34023.6%
VC/PE Firms37,884,21457.5%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top Shareholders

Top 25 shareholders own 76.34% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
21.2%
Lundbeckfonden BioCapital
13,950,686US$12.8m0%0.22%
10.4%
Kurma Partners SA
6,821,133US$6.3m0%99.87%
9.37%
Vivo Capital, LLC
6,173,439US$5.7m0%0.51%
5.99%
HBM Partners Ltd.
3,944,492US$3.6m0%0.4%
5.53%
Samsara BioCapital LLC
3,640,015US$3.3m0%0.46%
5.09%
Novo Holdings A/S
3,354,449US$3.1m-24.3%no data
3.55%
PFM Health Sciences, LP
2,341,107US$2.2m0%0.15%
3.34%
Morgan Stanley, Investment Banking and Brokerage Investments
2,202,085US$2.0m11.7%no data
3.2%
Marshall Wace LLP
2,105,262US$1.9m0%no data
2.72%
Sunstone Life Science Ventures A/S
1,791,490US$1.6m0%52.81%
2.51%
Bank of America Corporation, Asset Management Arm
1,651,515US$1.5m0%no data
1.31%
Pivotal BioVenture Partners LLC
864,197US$795.1k0%0.36%
0.75%
Logos Global Management, L.P.
493,827US$454.3k0%0.06%
0.3%
Bridgeway Capital Management, LLC
199,623US$183.7k60.2%no data
0.29%
Soleus Capital Management, L.P.
192,670US$177.3k0%0.01%
0.16%
UBS Asset Management AG
107,906US$99.3k3,190%no data
0.15%
Renaissance Technologies LLC
97,000US$89.2k-46.4%no data
0.13%
Amy Sullivan
84,632US$77.9k13.8%no data
0.12%
Mai-Britt Zocca
76,471US$70.4k19.5%no data
0.092%
Acadian Asset Management LLC
60,650US$55.8k0%no data
0.051%
Geode Capital Management, LLC
33,307US$30.6k0%no data
0.048%
Qasim Ahmad
31,350US$28.8k0%no data
0.046%
Two Sigma Investments, LP
30,000US$27.6k0%no data
0.04%
Hudson River Trading LLC, Asset Management Arm
26,646US$24.5k0%no data
0.027%
Virtu Financial LLC, Asset Management Arm
17,954US$16.5k0%no data

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/01/02 16:32
End of Day Share Price 2024/12/31 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

IO Biotech, Inc. is covered by 7 analysts. 4 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Emily BodnarH.C. Wainwright & Co.
Christopher HowertonJefferies LLC
Roger SongJefferies LLC